Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-006370
Filing Date
2015-11-16
Accepted
2015-11-16 16:14:18
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_111615.htm 10-Q 766019
2 EXHIBIT 10.1 exh_101.htm EX-10.1 282006
3 EXHIBIT 31.1 exh_311.htm EX-31.1 6846
4 EXHIBIT 31.2 exh_312.htm EX-31.2 6843
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3628
12 GRAPHIC exh101.jpg GRAPHIC 21229
13 GRAPHIC core.jpg GRAPHIC 25516
14 GRAPHIC argos.jpg GRAPHIC 10675
  Complete submission text file 0001171843-15-006370.txt   4891729

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE args-20150930.xml EX-101.INS 700413
7 XBRL SCHEMA FILE args-20150930.xsd EX-101.SCH 61610
8 XBRL CALCULATION FILE args-20150930_cal.xml EX-101.CAL 35263
9 XBRL DEFINITION FILE args-20150930_def.xml EX-101.DEF 413838
10 XBRL LABEL FILE args-20150930_lab.xml EX-101.LAB 358014
11 XBRL PRESENTATION FILE args-20150930_pre.xml EX-101.PRE 431751
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

EIN.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 151234615
SIC: 2834 Pharmaceutical Preparations